Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates
NCT ID: NCT03474978
Last Updated: 2023-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
320 participants
INTERVENTIONAL
2018-10-19
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Major Complications Related to PICC and Midline Insertion
NCT02489721
Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites
NCT04900740
Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study
NCT05729321
Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics
NCT05346406
Midline Catheter and Its Impact on Central Lines Removal in ICU
NCT03675711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Upper Extremity Insertion
Peripherally Inserted Central Venous Cather (PICC) inserted in upper extremity
Peripherally Inserted Central Venous Cather (PICC)
Location of the PICC insertion will be randomized and compared
Lower Extremity Insertion
Peripherally Inserted Central Venous Cather (PICC) inserted in lower extremity
Peripherally Inserted Central Venous Cather (PICC)
Location of the PICC insertion will be randomized and compared
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripherally Inserted Central Venous Cather (PICC)
Location of the PICC insertion will be randomized and compared
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Peripherally inserted central venous catheter (PICC) line insertion planned as part of NICU care
3. Venous access available in both upper(above umbilicus) and lower body
Exclusion Criteria
2. Hemangioma, lymphangioma or malformations in the region of insertion
3. Major chromosomal anomalies
4 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amuchou Soraisham
Neonatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amuchou Soraisham, MD
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foothills Medical Centre
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB17-2371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.